Deerland receives GRAS No Objection Letter from FDA for probiotic DE111

Published: 15-Aug-2019
Ingredients Regulatory Microbiology Active Nutrition Food

In addition to the FDA letter, DE111 has previously received non-Novel Food status in both Canada and Australia, as well as approval as a natural health product ingredient by Health Canada

Deerland Probiotics and Enzymes is proud to announce that the FDA has issued a GRAS (Generally Recognised As Safe) No Objection Letter for its branded probiotic strain, Bacillus subtilis DE111.

A “Letter of No Objection” refers to the letter sent by the FDA confirming that they do not question the basis for the GRAS self-affirmation notification established and submitted by Deerland.

Through the GRAS notification programme, companies voluntarily submit their self-affirmation documentation dossier, substantiated by extensive research and independent, qualified subject matter expert review, that a specific ingredient is Generally Recognised As Safe.

The “Letter of No Objection” means that FDA has reviewed all of the scientific data on DE111, and has no questions or concerns regarding its safety.

Further, DE111 is Star-K Kosher certified and Non-GMO Project verified.

“We are excited to receive the FDA’s no objection letter for DE111. It highlights the extensive research, including the clinical trials that have been conducted by our team, and we are proud of this accomplishment,” said Scott Ravech, CEO of Deerland.

  • Companies:
  • Deerland Enzymes
See more

You may also like

Ingredients

Deerland granted patent for Bacillus subtilis probiotic

Read more
The patent summarises studies of 30, 60 and 90 days in individuals with bowel irregularity who consumed B. subtilis, all resulting in measurable improvements

Trending Articles

  1. Rousselot to spotlight holistic benefits of collagen peptides at Vitafoods Europe 2024 The company will highlight three new clinical studies that support new benefits concerning its PEPTAN collagen peptide brand
  2. Tereos unveils new Innovation Centre for European customers The novel centre brings newly established laboratories for the food, pharmaceutical and cosmetics industries, as well as upgraded analytical technologies
  3. Arla Foods Ingredients new beverage concept for nutrition-conscious gamers The energy drink contains 15g of protein, taurine, magnesium, zinc, caffeine and vitamins A, B3, B6 and B12
  4. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

You may also like

Ingredients

Deerland granted patent for Bacillus subtilis probiotic

The patent summarises studies of 30, 60 and 90 days in individuals with bowel irregularity who consumed <i>B. subtilis</i>, all resulting in measurable improvements
Regulatory

ADM completes Deerland Probiotics acquisition

Deerland Probiotics & Enzymes is a provider of dietary supplements using probiotic, prebiotic, and enzyme technology
Regulatory

Deerland launches website to educate consumers on probiotics

Specifically, the website provides information and resources on the company's DE111 probiotic
Regulatory

Deerland probiotic DE111 attains health claims in Australia

Companies seeking to make a general level health claim for a food ingredient in Australia and New Zealand must perform a review of evidence of a causal food-health relationship
Ingredients

Deerland Probiotics & Enzymes positioned to collaborate with customers worldwide

Customers now have full access to an expanded portfolio of science-backed probiotic, prebiotic and enzyme technologies
Ingredients

Enzyme blend ProHydrolase potentiates amino acid uptake

A newly published study adds to the portfolio of research demonstrating that ProHydolase, a proprietary protease enzyme blend from Deerland Probiotics & Enzymes, enhances the benefit of whey protein when taken together
Ingredients

Deerland acquires Bifodan to boost global footprint

Acquisition gives the US-based company greater European reach with HQ in Denmark
Subscribe now